Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-09T07:53:17.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T04:09:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T01:30:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.5 to v2.16.6 and changed the date from April 9, 2025, to July 14, 2025.
    Difference
    0.9%
    Check dated 2025-07-18T22:12:16.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.
    Difference
    4%
    Check dated 2025-07-11T17:48:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    4%
    Check dated 2025-07-04T13:15:34.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.